Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-02-25 @ 5:34 PM
Study NCT ID:
NCT05153395
Status:
SUSPENDED
Last Update Posted:
2025-12-19
First Post:
2021-11-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation
Sponsor:
University of Missouri-Columbia
Organization:
Study Overview
Official Title:
Novel Treatment for Brain Insulin Resistance and Hypoperfusion
Status:
SUSPENDED
Status Verified Date:
2025-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Interim data and power analysis
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this project is to examine the impact of increases in brain insulin on sympathetic nervous system activity, as well as peripheral and cerebral blood flow in humans.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: